E-MTAB-1572 - Proteomic profiling by array of prostate cancer tumor samples with different sensitivities to androgen deprivation and under different severities of hypoxia
Released on 15 April 2013, last updated on 3 June 2014
To examine changes in tyrosine kinase activity in prostate cancer tumors developing resistance to androgen deprivation therapy and to compare these to changes in tyrosine kinase activity occuring in cell lines exposed to oxygen deficiency (hypoxia)
proteomic profiling by array, ex vivo, translational bias
Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer. Røe K, Bratland Å, Vlatkovic L, Ragnum HB, Saelen MG, Olsen DR, Marignol L, Ree AH. :e63723 (2013), Europe PMC 23675504
Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer. Kathrine Røe, Åse Bratland, Ljiljana Vlatkovic, Harald Bull Ragnum, Marie Grøn Saelen, Dag Rune Olsen, Laure Marignol, Anne Hansen Ree.